Publications by authors named "Carolina Barragan"
Br J Dermatol
October 2024
Article Synopsis
- ABP 654 is a biosimilar to ustekinumab, sharing identical amino acid sequences and similar safety and pharmacokinetics in healthy individuals.
- A clinical study was conducted to compare the efficacy and safety of ABP 654 versus ustekinumab in patients with moderate-to-severe plaque psoriasis, focusing on improvements in psoriasis severity.
- Results showed no significant difference in efficacy (PASI improvement) between ABP 654 and ustekinumab, and both treatments exhibited similar safety and immunogenicity profiles.
